Rami Ayoun Alsoud - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Rami Ayoun Alsoud

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Journal of Asthma and Allergy|May 27, 2026

Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling StudyPradeep B Lukka, Robert C Penland, Ari Brekkan, et al.

Journal of Pharmaceutical Sciences|June 30, 2024

Model-Based Interspecies Scaling for Predicting Human Pharmacokinetics of CB 4332, a Complement Factor I ProteinRami Ayoun Alsoud, Natacha Le Moan, Lars Holten-Andersen, et al.

Frontiers in Pharmacology|March 31, 2023

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug developmentRami Ayoun Alsoud, Robin J Svensson, Elin M Svensson, et al.

The Journal of Infectious Diseases|February 19, 2021

Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical DataSaskia E Mudde, Rami Ayoun Alsoud, Aart van der Meijden, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Journal of Asthma and Allergy|May 27, 2026

Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling StudyPradeep B Lukka, Robert C Penland, Ari Brekkan, et al.

Journal of Pharmaceutical Sciences|June 30, 2024

Model-Based Interspecies Scaling for Predicting Human Pharmacokinetics of CB 4332, a Complement Factor I ProteinRami Ayoun Alsoud, Natacha Le Moan, Lars Holten-Andersen, et al.

Frontiers in Pharmacology|March 31, 2023

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug developmentRami Ayoun Alsoud, Robin J Svensson, Elin M Svensson, et al.

The Journal of Infectious Diseases|February 19, 2021

Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical DataSaskia E Mudde, Rami Ayoun Alsoud, Aart van der Meijden, et al.

Pageof 1